Related Experiment Video
Updated: Jul 14, 2026

Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins
Published on: August 31, 2017
Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis
Minoo Battiwalla1, Yiyuan Wu, Rajinder P S Bajwa
1Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14202, USA. minoo.battiwalla@roswellpark.org <minoo.battiwalla@roswellpark.org>
Insights
Ganciclovir effectively prevents cytomegalovirus (CMV) disease after stem cell transplants but may harm immune recovery. This antiviral drug suppresses T-lymphocyte proliferation, potentially impacting long-term transplant outcomes.
Area of Science:
- Immunology
- Hematology
- Virology
Background:
- Cytomegalovirus (CMV) disease mortality in allogeneic hematopoietic stem cell transplant (HSCT) recipients has decreased due to ganciclovir. However, ganciclovir has not improved overall survival and recurrent CMV antigenemia predicts malignancy relapse.
- Prolonged ganciclovir exposure is linked to increased relapse rates in HSCT patients, suggesting potential negative impacts beyond CMV control.
Purpose of the Study:
- To investigate the hypothesis that ganciclovir negatively affects immune reconstitution post-HSCT.
- To determine the in vitro effect of ganciclovir on normal human T-lymphocyte activation and proliferation.
Main Methods:
- Assessed T-lymphocyte activation and proliferation using PHA-induced (3)H-thymidine uptake.
- Measured the impact of ganciclovir and foscarnet at therapeutic concentrations on lymphocyte responses.
- Evaluated ganciclovir's effect on bromodeoxyuridine incorporation, lymphocyte survival, and apoptosis.
Main Results:
- Therapeutic concentrations of ganciclovir significantly reduced T-lymphocyte activation and proliferation.
- Ganciclovir impaired DNA synthesis in proliferating lymphocytes, as indicated by reduced bromodeoxyuridine incorporation.
- Foscarnet did not exhibit the same suppressive effect on T-lymphocyte proliferation at tested concentrations. Ganciclovir did not induce lymphocyte apoptosis or impair survival.
Conclusions:
- Ganciclovir suppresses T-lymphocyte proliferation in vitro by inhibiting DNA synthesis.
- These findings suggest ganciclovir may have detrimental implications for T-lymphocyte function and immune reconstitution following allogeneic bone marrow transplantation (BMT).
- Further research is warranted to explore strategies to mitigate ganciclovir's impact on immune recovery in HSCT recipients.
Abstract:
Cytomegalovirus (CMV) disease-related mortality in allogeneic hematopoietic stem cell transplant (HSCT) recipients has dramatically declined because of ganciclovir prophylaxis and preemptive therapeutic strategies. However, ganciclovir has not improved overall survival in randomized studies despite effectively preventing overt CMV disease. Moreover, recurrent posttransplant CMV antigenemia, associated with prolonged ganciclovir exposure, is a predictor of increased relapse of malignancy. We examined the hypothesis that ganciclovir itself may have a negative impact on immune reconstitution by testing the effect of ganciclovir on normal human lymphocytes in vitro. T-lymphocyte activation and proliferation, as measured by PHA-induced (3)H-thymidine uptake, was greatly reduced at therapeutic concentrations of ganciclovir (10 microg/mL) but not for foscarnet (300 microM/L). Moreover, ganciclovir impaired bromodeoxyuridine incorporation in proliferating lymphocytes, but did not impair lymphocyte survival or induce lymphocyte apoptosis. Collectively, these results show that ganciclovir suppresses T-lymphocyte proliferation in vitro by inhibiting DNA synthesis; with implications for T-lymphocyte function following allogeneic BMT.
More Related Videos
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Related Concept Videos
Antiviral Nucleoside Inhibitors
Cytomegalovirus Disease
Inhibitors of Viral Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Virion Maturation and Assembly
Inhibitors Of Virion Release